Hydroxyzine Use and Mortality in Patients Hospitalized for COVID-19: A Multicenter Observational Study

Hydroxyzine Use and Mortality in Patients Hospitalized for COVID-19: A Multicenter Observational Study

(1) Background: Based on its antiviral activity, anti-inflammatory properties, and functional inhibition effects on the acid sphingomyelinase/ceramide system (FIASMA), we sought to examine the potential usefulness of the H1 antihistamine hydroxyzine in patients hospitalized for COVID-19. (2) Methods...

Full description

Bibliographic Details
Main Authors: Marina Sánchez-Rico, Frédéric Limosin, Raphaël Vernet, Nathanaël Beeker, Antoine Neuraz, Carlos Blanco, Mark Olfson, Cédric Lemogne, Pierre Meneton, Christel Daniel, Nicolas Paris, Alexandre Gramfort, Guillaume Lemaitre, Pedro De La Muela, Elisa Salamanca, Mélodie Bernaux, Ali Bellamine, Anita Burgun, Nicolas Hoertel, on behalf of AP-HP/Université de Paris/INSERM COVID-19 Research Collaboration/AP-HP COVID CDR Initiative/“Entrepôt de Données de Santé” AP-HP Consortium
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Journal of Clinical Medicine
Subjects:
COVID-19
SARS-CoV-2
hydroxyzine
FIASMA
treatment
inpatients
Online Access:https://www.mdpi.com/2077-0383/10/24/5891

Internet

https://www.mdpi.com/2077-0383/10/24/5891

Similar Items